When was Celltrio founded?

Celltrio was founded in 2018 and raised its 1st funding round 7 years after it was founded.

Where is Celltrio located?

Celltrio is headquartered in Fremont, United States.

How many employees does Celltrio have?

As of Aug 31, 2026, the latest employee count at Celltrio is 36.

Is Celltrio a funded company?

Celltrio is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Jun 17, 2025.

When was the latest funding round of Celltrio?

Celltrio's latest funding was a $***** Series B round on Jun 17, 2025, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.3B in funding in 2026 to date.

Where does Celltrio rank among its competitors?

Celltrio ranks 9th amongst 34 active competitors, of which 10 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellares, which secured $50M in Jun, 2026.

Who are the top competitors of Celltrio?

Celltrio's top competitors include Multiply Labs, Oribiotech and Cellares. Among them, Cellares secured the most recent funding round in June, 2026.

Celltrio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of automated biobanking and cell culture systems. It has developed CryoStor and RoboStor lines of liquid nitrogen freezers for biobanking applications. The company has also developed integrated robotic solutions which combine incubators, centrifuges and liquid handlers using software and LIMS systems.

Website: celltrio.com
Email ID: *****@celltrio.com

Key Metrics

Founded Year

2018

Location

Fremont, United States

Stage

Series B

Total Funding

$15M in 1 round

Latest Funding Round

Series B, Jun 17, 2025, $*****

Investors

Premier Partners & 1 more

Ranked

9^th among 34 active competitors

Employee Count

36 as on Aug 31, 2026

Similar Companies

Multiply Labs & 33 more

View Celltrio's full profile

Celltrio has raised a total funding of $15M over 1 round. Its latest funding round was a Series B round on Jun 17, 2025 for $*****. 1 investor participated in its latest round. Celltrio has 2 institutional investors.

Here is the list of recent funding rounds of Celltrio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 17, 2025	1204528	Series B	8400472	3315388	4320326	4971040

Access funding benchmarks and valuations. Sign up today!

View details of Celltrio's funding rounds and investors

The founders of Celltrio are Charlie Duncheon and Jin-Oh Kim.

Here are the details of Celltrio's key team members:

Charlie Duncheon: Co-Founder & CEO of Celltrio.
Contact Info: 1 email address
Jin-Oh Kim: Co-Founder & CTO of Celltrio.

View details of Celltrio's Founder profiles and Board Members

Celltrio's employee count trend

Celltrio has 36 employees as of Aug 26. Here is Celltrio's employee count trend over the years:

Uncover Celltrio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Celltrio include Multiply Labs, Oribiotech and Cellares. Here is the list of Top 10 competitors of Celltrio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Multiply Labs 2016, San Francisco (United States), Series A	Manufacturer of precision medicines through innovative robotic technology	$41.3M	Zillionize, Casdin Capital & 22 others	69/100
2nd	Oribiotech 2015, London (United Kingdom), Series B	Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool	$143M	Northpond Ventures, Novalis LifeSciences ... & 17 others	66/100
3rd	Cellares 2019, San Francisco (United States), Series D	Manufacturer of a medical device for cell-based therapy	$682M	Eclipse, Decheng Capital & 17 others	64/100
4th	Cellular Origins 2022, Melbourn (United Kingdom), Series A	Provider of automated manufacturing solution for cell and gene therapy	$40M	Johnson & Johnson, The Technology Partnership ... & 3 others	59/100
5th	Astraveus 2016, Paris (France), Seed	Provider of a device for autologous cell and gene therapies	$18M	AdBio partners, EIC Fund & 5 others	55/100
6th	Unicorn Biotechnologies 2020, Sheffield (United Kingdom), Seed	Developer of bioreactors for cell-based manufacturing	$3.45M	Acequia Capital, Climate Capital & 9 others	44/100
7th	Shenzhen Shenyan Biotechnology 2014, Shenzhen (China), Series B	Developer of automated cell processing system	$56.7M	Eight Roads Ventures, Tasly & 4 others	40/100
8th	ThermoGenesis 1986, Rancho Cordova (United States), Public	Provider of automated technologies for cell-based therapeutics and bio-processing	-	Bay City Capital, HHS	40/100
9th	Celltrio 2018, Fremont (United States), Series B	Developer of automated biobanking and cell culture systems	$15M	Premier Partners, Asia2G Capital	39/100
10th	Cell X Technologies 2017, Cleveland (United States), Funding Raised	Developer of regenerative medicine to measure and manage human cell sources	-	Innovation Works, Denniston Family Office ... & 2 others	35/100